Related Experiment Videos
Update on solid tumor management in childhood
1Department of Surgery, Stanford University Medical Center, California.
The Surgical Clinics of North America
|December 1, 1992
Summary
Pediatric surgeons must adapt to evolving cancer therapies, including radiation, chemotherapy, and immunotherapy. Understanding new tumor markers and participating in research are crucial for advancing pediatric solid tumor treatment.
Area of Science:
- Pediatric oncology
- Surgical oncology
- Cancer research
Background:
- Surgery is integral to treating childhood solid tumors.
- Therapeutic approaches are becoming increasingly complex.
Purpose of the Study:
- To highlight the evolving role of pediatric surgeons in multidisciplinary cancer care.
- To emphasize the need for surgeons to stay abreast of therapeutic advancements.
Main Methods:
- Review of current trends in pediatric oncology.
- Discussion of emerging technologies and research protocols.
Main Results:
- New tumor markers offer prognostic and therapeutic insights.
- Advances in immunotherapy and molecular biology impact surgical decisions.
Conclusions:
- Pediatric surgeons require updated knowledge of radiation, chemotherapy, and immunotherapy.
- Active participation in cooperative research groups is essential for answering critical surgical questions and obtaining specimens.